Contact
On our page you will find a multitude of information that may be of your interest. If you have any questions, do not hesitate to contact our team:
Articles
and news
Natural killer (NK) cells represent one of the three groups of lymphocytes, alongside T and B cells. Unlike the latter, they belong to the innate immune system and constitute the first line of defense against a wide range of pathogens. Simply put, their function is to destroy cells—whether they are infected by a pathogen or potentially harmful cancerous cells.
NK cells are naturally programmed to detect and eliminate infected or cancerous cells that express specific markers of malignancy, while “sparing” healthy cells that do not express such markers.
However, certain alterations, such as mutations, can impair these cells’ ability to distinguish between healthy and malignant cells. Instead, they may indiscriminately “kill” all cells, leading to severe autoimmune diseases where the body attacks itself.
To analyze the profile of NK cells, the following steps must be followed:
For the centrifugation process, the Digicen 22 and Unicen 21 centrifuges are ideal due to their advanced features and versatility. The Digicen 22 provides digital control of speed and time, enabling precise adjustments of centrifugal forces with high reproducibility. Additionally, it features the REI System (Rotor Easy to Install), facilitating quick and easy rotor exchange. On the other hand, the compact and robust design of the Unicen 21 makes it an excellent choice for laboratories prioritizing efficiency and ease of use.
Determining the toxicity profile of NK cells in the context of autoimmune diseases is of great importance for establishing treatment strategies. This can be achieved using the above-described protocol, where centrifugation plays a critical role.
If you wish to receive our latest news periodically, do not hesitate to subscribe to our Newsletter.
* Required fields. These fields must be completed to submit the form. Thank you
I have read and accept the privacy policy of the Company.
I agree to receive your commercial communications